Epidemiology, Pathophysiology, and Treatment of Hypertension in Ischaemic Stroke Patients

Rothwell, 2001, The high cost of not funding stroke research: A comparison with heart disease and cancer, Lancet, 357, 1612, 10.1016/S0140-6736(00)04730-9 Bamford, 1991, Classification and natural history of clinically identifiable subtypes of cerebral infarction, Lancet, 337, 1521, 10.1016/0140-6736(91)93206-O Kumar, 2010, Medical complications after stroke, Lancet Neurol, 9, 105, 10.1016/S1474-4422(09)70266-2 Santos, 2009, The neuroanatomical model of post-stroke depression: Towards a change of focus?, J Neurol Sci, 283, 158, 10.1016/j.jns.2009.02.334 Saka, 2009, Cost of stroke in the United Kingdom, Age Ageing, 38, 27, 10.1093/ageing/afn281 Goldstein, 2011, Guidelines for the primary prevention of stroke. A guideline for healthcare professionals from the American Heart Association/American Stroke Association, Stroke, 42, 517, 10.1161/STR.0b013e3181fcb238 2010 Harmsen, 2006, Long-term risk factors for stroke: Twenty-eight years of follow-up of 7457 middle-aged men in Goteborg, Sweden, Stroke, 37, 1663, 10.1161/01.STR.0000226604.10877.fc Kissela, 2005, Epidemiology of ischemic stroke in patients with diabetes, Diabet Care, 28, 355, 10.2337/diacare.28.2.355 Mancia, 2007, 2007 Guidelines for the management of arterial hypertension, Eur Heart J, 28, 1462 Qureshi, 2005, Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition Examination Surveys 1976 to 2000, Med Sci Monit, 11, CR403 Johansson, 1999, Hypertension mechanisms causing stroke, Clin Exp Pharmacol Physiol, 26, 563, 10.1046/j.1440-1681.1999.03081.x Jones, 2003, Hypertension and cerebrovascular disease, Sem Cerebrovasc Dis Stroke, 3, 144, 10.1053/j.scds.2003.00.029 Agmon, 2000, Independent association of high blood pressure and aortic atherosclerosis: A population-based study, Circulation, 102, 2087, 10.1161/01.CIR.102.17.2087 van der Linden, 2007, The topography of aortic atherosclerosis enhances its precision as a predictor of stroke, Ann Thoracic Surg, 83, 2087, 10.1016/j.athoracsur.2007.02.020 Su, 2001, Hypertension status is the major determinant of carotid atherosclerosis: A community-based study in Taiwan, Stroke, 32, 2265, 10.1161/str.32.10.2265 Lernfelt, 2002, Cerebral atherosclerosis as predictor of stroke and mortality in representative elderly population, Stroke, 33, 224, 10.1161/hs0102.102009 Hollander, 2002, Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: The Rotterdam study, Circulation, 105, 2872, 10.1161/01.CIR.0000018650.58984.75 Wardlaw, 2009, Lacunar stroke is associated with diffuse blood–brain barrier dysfunction, Ann Neurol, 65, 194, 10.1002/ana.21549 Lee, 2007, Vascular permeability precedes spontaneous intracerebral hemorrhage in stroke-prone spontaneously hypertensive rats, Stroke, 38, 3289, 10.1161/STROKEAHA.107.491621 Lippoldt, 2000, Structural alterations of tight junctions are associated with loss of polarity in stroke-prone spontaneously hypertensive rat blood-brain barrier endothelial cells, Brain Res, 885, 251, 10.1016/S0006-8993(00)02954-1 Wolburg, 1994, Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes, J Cell Sci, 107, 1347, 10.1242/jcs.107.5.1347 Kniesel, 1996, Development of blood-brain barrier tight junctions in the rat cortex, Dev Brain Res, 96, 229, 10.1016/0165-3806(96)00117-4 Ishida, 2006, Expression of glucose transporter-1 and aquaporin-4 in the cerebral cortex of stroke-prone spontaneously hypertensive rats in relation to the blood-brain barrier function, Am J Hypertens, 19, 33, 10.1016/j.amjhyper.2005.06.023 Al-Sarraf, 2003, Effect of hypertension on the integrity of blood brain and blood CSF barriers, cerebral blood flow and CSF secretion in the rat, Brain Res, 975, 179, 10.1016/S0006-8993(03)02632-5 Castillo, 2004, Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome, Stroke, 35, 520, 10.1161/01.STR.0000109769.22917.B0 Sandset, 2011, The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): A randomised, placebo-controlled, double-blind trial, Lancet, 377, 741, 10.1016/S0140-6736(11)60104-9 Adams, 2007, Circulation, 115, e478, 10.1161/CIRCULATIONAHA.107.181486 Heitsch, 2007, Management of hypertension in the setting of acute ischemic stroke, Curr Hypertens Rep, 9, 506, 10.1007/s11906-007-0092-5 Adams, 2003, Guidelines for the early management of patients with ischemic stroke: A scientific statement from the stroke council of the American Stroke Association, Stroke, 34, 1056, 10.1161/01.STR.0000064841.47697.22 Wang, 2003, Antihypertensive treatment and prevention of stroke and dementia, Semin Cerebrovasc Dis Stroke, 3, 155, 10.1053/j.scds.2003.00.025 Mancia, 2004, Prevention and treatment of stroke in patients with hypertension, Clin Ther, 26, 631, 10.1016/S0149-2918(04)90065-3 Sacco, 2006, Circulation, 113, e409, 10.1161/circ.113.10.e409 Mark, 2000, Stroke: Development, prevention and treatment with peptidaseinhibitors, Peptides, 21, 1965, 10.1016/S0196-9781(00)00346-6 Bentley, 2005, Pharmacological treatment of ischemic stroke, Pharmacol Ther, 108, 334, 10.1016/j.pharmthera.2005.05.006 Papademetriou, 2004, Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: The study on cognition and prognosis in the elderly (SCOPE), J Am Coll Cardiol, 44, 1175 Diez, 2006, Review of the molecular pharmacology of Losartan and its possible relevance to stroke prevention in patients with hypertension, Clin Ther, 28, 832, 10.1016/j.clinthera.2006.06.002 Williams, 2006, Circulation, 113, 1213, 10.1161/CIRCULATIONAHA.105.606962 De Caterina, 2011, The role of beta-blockers as first-line therapy in hypertension, Curr Atheroscler Rep, 13, 147, 10.1007/s11883-010-0157-9 Prichard, 2001, Beta-adrenergic blocking drugs in the treatment of hypertension, Blood Press, 10, 366, 10.1080/080370501753400665 De Caterina, 2010, Why beta-blockers should not be used as first choice in uncomplicated hypertension, Am J Cardiol, 105, 1433, 10.1016/j.amjcard.2009.12.068 Lindholm, 2005, Should beta blockers remain as first choice in the treatment of primary hypertension? A meta-analysis, Lancet, 366, 1545, 10.1016/S0140-6736(05)67573-3 Dahlöf, 2007, Prevention of stroke in patients with hypertension, Am J Cardiol, 100, 17J, 10.1016/j.amjcard.2007.05.010 Dahlöf, 2009, Prevention of stroke: New evidence, Eur Heart J Suppl, 11, F33, 10.1093/eurheartj/sup026 Yusuf, 2008, Telmisartan to prevent recurrent stroke and cardiovascular events, New Engl J Med, 359, 1225, 10.1056/NEJMoa0804593 Ford, 2009, Effect of telmisartan on cognitive decline following stroke: PRoFESS cognitive sub-study, Stroke, 40, e274 Savoia, 2006, Angiotensin II/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase, J Hypertens, 24, 2417, 10.1097/01.hjh.0000251902.85675.7e Mukaddam-Daher, 2009, Hemodynamic and cardiac effects of chronic eprosartan and moxonidine therapy in stroke-prone spontaneously hypertensive rats, Hypertens, 53, 775, 10.1161/HYPERTENSIONAHA.108.126524 Matsumoto, 2007, Antihypertensive efficacy and cerebral hemodynamic advantage of olmesartan medoxomil compared with amlodipine in poststroke patients [poster 56], Arch Phys Med Rehab, 88, e21, 10.1016/j.apmr.2007.08.089 Unger, 2009, The rationale for choosing telmisartan and ramipril in the ONTARGET programme, Eur Heart J Suppl, 11, F3, 10.1093/eurheartj/sup033 Teo, 2009, Clinical evidence from ONTARGET: Proven cardio- and vascular protection, Eur Heart J Suppl, 11, F9, 10.1093/eurheartj/sup032 McMurray, 2006, The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: An analysis of the valsartan in acute myocardial infarction trial (VALIANT), J Am Coll Cardiol, 47, 726, 10.1016/j.jacc.2005.09.055 Bugnicourt, 2008, Stroke secondary prevention and blood pressure reduction: An observational study of the use of PROGRESS therapy, Fund Clin Pharmacol, 22, 217, 10.1111/j.1472-8206.2008.00570.x 2001, Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack, Lancet, 358, 1033, 10.1016/S0140-6736(01)06178-5 Brugts, 2009, The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: A combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials, Eur Heart J, 30, 1385, 10.1093/eurheartj/ehp103 Hasegawa, 2010, Efficacy and safety of diuretics in combination with perindopril in hypertensive stroke patients: Results of the Japan Perindopril and Diuretics on Cerebrovascular Disease Study (J-PADOC), Blood Press Suppl, 1, 10, 10.3109/08037050903513497 Yusuf, 2000, Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients, New Engl J Med, 342, 145, 10.1056/NEJM200001203420301 Gianni, 2007, Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients, Eur Heart J, 28, 1382, 10.1093/eurheartj/ehm017 Law, 2009, Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies, BMJ, 338, 1665, 10.1136/bmj.b1665 Wang, 2007, Prevention of stroke and myocardial infarction by amlodipine and angiotensin receptor blockers: A quantitative overview, Hypertens, 50, 181, 10.1161/HYPERTENSIONAHA.107.089763 Chen, 2010, Calcium channel blockers versus other classes of drugs for hypertension, Cochrane Database Syst Rev, 8, CD003654 Stanton, 2001, Effects of blood pressure lowering with amlodipine or lisinopril on vascular structure of the common carotid artery, Clin Sci, 101, 455, 10.1042/CS20010045 Takei, 2009, Comparison of the anti-hypertensive effects of the L/N-type calcium channel antagonist cilnidipine, and the L-type calcium channel antagonist amlodipine in hypertensive patients with cerebrovascular disease, Intern Med, 48, 1357, 10.2169/internalmedicine.48.2158 Angeli, 2004, Calcium channel blockade to prevent stroke in hypertension: A meta-analysis of 13 studies with 103,793 subjects, Am J Hypertens, 17, 817, 10.1016/S0895-7061(04)00863-5 Wright, 2009, First-line drugs for hypertension, Cochrane Database Syst Rev, 3, CD001841 Laurent, 2010, Combination therapy in hypertension: Where do we stand, J Hypertens, 28, e611, 10.1097/01.hjh.0000383858.34243.91 Amenta, 2009, Nicardipine use in cerebrovascular disease: A review of controlled clinical studies, J Neurol Sci, 283, 219, 10.1016/j.jns.2009.02.335 Matsubara, 2008, Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats, Eur J Pharmacol, 580, 201, 10.1016/j.ejphar.2007.10.072 Lisk, 1993, Should hypertension be treated after acute stroke? A randomised controlled trial using single photon emission computed tomography, Arch Neurol, 50, 855, 10.1001/archneur.1993.00540080060015 Fagan, 2006, Hypertension after cerebral ischemia: Candesartan provides neurovascular protection, J Hypertens, 24, 535, 10.1097/01.hjh.0000209990.41304.43 Kozak, 2008, Vascular protection with candesartan after experimental acute stroke in hypertensive rats: A dose-response study, J Pharmacol Exp Ther, 326, 773, 10.1124/jpet.108.139618 Schrader, 2003, The ACCESS study: Evaluation of acute candesartan cilexetil therapy in stroke survivors, Stroke, 34, 1699, 10.1161/01.STR.0000075777.18006.89 Wahlgren, 1994, Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke, Cerebrovasc Dis, 4, 204, 10.1159/000108483 Ahmed, 2000, Effect of intravenous nimodipine on blood pressure and outcome after acute stroke, Stroke, 31, 1250, 10.1161/01.STR.31.6.1250 Ahmed, 2001, High initial blood pressure after acute stroke is associated with poor functional outcome, J Intern Med, 249, 467, 10.1046/j.1365-2796.2001.00831.x 2006, Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: Rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122), Int J Stroke, 1, 245, 10.1111/j.1747-4949.2006.00059.x Anderson, 2008, Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): A randomised pilot trial, Lancet Neurol, 7, 391, 10.1016/S1474-4422(08)70069-3